Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 15, 2023

Primary Completion Date

April 1, 2023

Study Completion Date

May 15, 2023

Conditions
Photoaging
Interventions
DEVICE

In a double-blinded fashion, 250 mg CANNAXR cream

Determining the Efficacy of topically applied CANNAXR cream in Decreasing UVA Premutagenic and Photoaging markers 8-oxo-dG and the common deletion. 250 mg TOPICAL CBD CANNAXR Cream will be randomized for application to a delineated 50 cm2 area of either the left or right, hip/buttocks skin twice daily for 2 weeks

DEVICE

Topical VEHICLE cream

Determining the Efficacy of topically applied VEHICLE cream in Decreasing UVA Premutagenic and Photoaging markers 8-oxo-dG and the common deletion. 250 mg VEHICLE cream will be randomized for application to a delineated 50 cm2 area of either the left or right, hip/buttocks skin twice daily for 2 weeks

Trial Locations (1)

33180

Center for Clinical and Cosmetic Research, Aventura

All Listed Sponsors
lead

MINO Labs, LLC

INDUSTRY